Asset Details
Do you wish to reserve the book?
Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers
Do you wish to request the book?
Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers
2021
Overview
Western literature lacks large-scale population studies comparing the influence of academic and high-volume (HV) versus low-volume (LV) cancer centers on gastric cancer oncologic outcomes.
The National Cancer Database from 2004 to 2016 was used.
22871 patients were studied. Patients with stage III signet-ring cell gastric carcinoma (SRGC) received neoadjuvant treatment (NAT) more frequently at academic and HV comprehensive cancer centers (OR: 4.27 and 2.42; p < 0.0001 and 0.009) compared to community centers. Patients with stage III non-SRGC (NSRGC) had a 2.4 times higher odds of receiving NAT at academic centers. The R1 resection rate for NSRGC was lower at academic centers (OR: 0.67; p = 0.0018). Lymph node harvest ≥15 nodes was 1.6 and 1.9 times higher at academic centers for NSRGC and SRGC, respectively. Patients treated at academic centers had a significantly improved overall survival (OS).
Treatment at academic centers is associated with significant improvements in oncologic metrics and OS.
[Display omitted]
•Academic outperform community centers in management of resectable gastric cancer.•Despite delay in treatment initiation, survival is improved at academic centers.•Survival is greater in signet-ring cell gastric cancer treated at academic centers.
Publisher
Elsevier Inc,Elsevier Limited
Subject
/ Academic Medical Centers - standards
/ Academic Medical Centers - statistics & numerical data
/ Adult
/ Aged
/ Cancer
/ Carcinoma, Signet Ring Cell - mortality
/ Carcinoma, Signet Ring Cell - surgery
/ Female
/ Humans
/ Male
/ Patients
/ Signet-ring cell gastric carcinoma
/ Stomach Neoplasms - mortality
/ Survival
/ Tumors
